Market LIVE
Published markets; coverage varies by country
Product profile · United States

OGSIVEO

 ·  Patent Litigation & Settlement History ↓

IngredientNIROGACESTAT HYDROBROMIDE
Application typeNDA
Application217677
Product002
Dosage formTABLET
RouteORAL
StrengthEQ 100MG BASE
Approval date2024-04-04
Marketing statusPrescription
Status event—
ApplicantSPRINGWORKS
Product source

Current GenericRadar decision

Year2030
SelectionDEEP_REVIEW
ReviewFINAL
Anchor typeREGULATORY_EXCLUSIVITY
Anchor date2030-11-27
Patent anchor2030-08-18
Exclusivity anchor2030-11-27
Protection date2043-05-19
First Final ANDA—
Status event—

GNR judgment: DEEP_REVIEW. Reference year: 2030. Anchor type: REGULATORY_EXCLUSIVITY. Patent anchor: 2030-08-18. Exclusivity anchor: 2030-11-27. Anchor date: 2030-11-27. Patent tail: yes. Exclusivity tail: no. Review status: FINAL. Historical detailed rationale is retained in the evidence snapshot; this is a structured English summary, not a literal translation.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
77954472030-08-18DS —YNTRUE_DS
English description not available.
———
77954472030-08-18ORANGE_BOOK —YNTRUE_DS
English description not available.
———
105900872039-08-09DS —NNDP
English description not available.
———
105900872039-08-09ORANGE_BOOK —NNDP
English description not available.
———
107109662039-08-09DS/U U-3754NNU
English description not available.
———
107109662039-08-09ORANGE_BOOK U-3754NNU
English description not available.
———
109411182039-08-09DS/U U-3754NNDP
English description not available.
———
109411182039-08-09ORANGE_BOOK U-3754NNDP
English description not available.
———
118207482039-08-09DP —NNDP
English description not available.
———
118207482039-08-09ORANGE_BOOK —NNDP
English description not available.
———
118457322039-08-09DS/U U-3754NNU
English description not available.
———
118457322039-08-09ORANGE_BOOK U-3754NNU
English description not available.
———
118846342039-08-09DP —NNDP
English description not available.
———
118846342039-08-09ORANGE_BOOK —NNDP
English description not available.
———
118846352039-08-09DP —NNDP
English description not available.
———
118846352039-08-09ORANGE_BOOK —NNDP
English description not available.
———
119052552039-08-09DP —NNDP
English description not available.
———
119052552039-08-09ORANGE_BOOK —NNDP
English description not available.
———
121163472039-08-09DP —NNDP
English description not available.
———
121163472039-08-09ORANGE_BOOK —NNDP
English description not available.
———
122971772039-08-09DP —NNDP
English description not available.
———
122971772039-08-09ORANGE_BOOK —NNDP
English description not available.
———
115043542042-07-08DP —NNDP
English description not available.
———
115043542042-07-08ORANGE_BOOK —NNDP
English description not available.
———
116125882042-07-08DP/U U-3754NNU
English description not available.
———
116125882042-07-08ORANGE_BOOK U-3754NNU
English description not available.
———
121102772042-07-08DP —NNDP
English description not available.
———
121102772042-07-08ORANGE_BOOK —NNDP
English description not available.
———
122342102042-07-08DP —NNPROCESS
English description not available.
———
122342102042-07-08ORANGE_BOOK —NNPROCESS
English description not available.
———
122470122042-07-08DP —NNPROCESS
English description not available.
———
122470122042-07-08ORANGE_BOOK —NNPROCESS
English description not available.
———
125995872042-07-08DP —NNOTHER
English description not available.
———
125995872042-07-08ORANGE_BOOK —NNOTHER
English description not available.
———
118076112042-09-08DP/U U-3754NNU
English description not available.
———
118076112042-09-08ORANGE_BOOK U-3754NNU
English description not available.
———
118447802042-09-08DP/U U-3754NNU
English description not available.
———
118447802042-09-08ORANGE_BOOK U-3754NNU
English description not available.
———
118722112043-05-19U U-3754NNU
English description not available.
———
118722112043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
119256192043-05-19U U-3754NNU
English description not available.
———
119256192043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
119256202043-05-19U U-3754NNU
English description not available.
———
119256202043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
119381162043-05-19U U-3754NNU
English description not available.
———
119381162043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
119510962043-05-19U U-3754NNU
English description not available.
———
119510962043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
119576622043-05-19U U-3754NNU
English description not available.
———
119576622043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
120114342043-05-19U U-3754NNU
English description not available.
———
120114342043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
120114352043-05-19U U-3754NNU
English description not available.
———
120114352043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
120362072043-05-19U U-3754NNU
English description not available.
———
120362072043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———
121382462043-05-19U U-3754NNU
English description not available.
———
121382462043-05-19ORANGE_BOOK U-3754NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NCE2023-11-272028-11-27English description not available.YY2028-11-27—Source
NCE2023-11-272028-11-27English description not available.YY2028-11-27
ODE-452
Full coverage date: 2028-11-27
Source
ODE-4522023-11-272030-11-27English description not available.YY2030-11-27
ODE-452
Full coverage date: 2030-11-27
Source
ODE*—2030-11-27————Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (32)
TypeDateRoleBasisSource
PATENT2030-08-18CANONICAL_ANCHOREnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2039-08-09FTO_TAILEnglish description not available.Source
PATENT2042-07-08FTO_TAILEnglish description not available.Source
PATENT2042-07-08FTO_TAILEnglish description not available.Source
PATENT2042-07-08FTO_TAILEnglish description not available.Source
PATENT2042-07-08FTO_TAILEnglish description not available.Source
PATENT2042-07-08FTO_TAILEnglish description not available.Source
PATENT2042-07-08FTO_TAILEnglish description not available.Source
PATENT2042-09-08FTO_TAILEnglish description not available.Source
PATENT2042-09-08FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
PATENT2043-05-19FTO_TAILEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—CANONICAL_ANCHOREnglish description not available.Source
REGULATORY_STATUS2030-11-27CANONICAL_DECISIONEnglish description not available.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.